New & Noteworthy

Submit New & Noteworthy

January 2021

RTA Intravenous Dexamethasone

QuVa Pharma, Inc

QuVa Pharma provides dexamethasone phosphate as a compounded sterile product in a ready-to-administer IV bag, now available for order under FDA Drug Shortage guidelines. This compounded sterile product (CSP) is available as 6 mg in 25 mL 0.9% sodium chloride IV bag. Updated recommendations for the COVID-19 Treatment Guidelines Panel from The National Institutes of Health and the World Health Organization Panel include systemic corticosteroids, like dexamethasone 6 mg daily, for hospitalized patients with severe and critical COVID-19.

QuVa Pharma, Inc

Click here to view product detail on Findit.

Current Issue